Eocene Ltd. (EOCN)
3.54
-0.08
(-2.21%)
USD |
NASDAQ |
Oct 09, 16:00
3.51
-0.03
(-0.85%)
After-Hours: 20:00
Eocene Price to Book Value : 0.2783 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.2783 |
| October 08, 2026 | 0.2846 |
| October 07, 2026 | 0.2718 |
| October 06, 2026 | 0.2641 |
| October 05, 2026 | 0.2712 |
| October 02, 2026 | 0.2838 |
| October 01, 2026 | 0.2677 |
| September 30, 2026 | 0.2744 |
| September 29, 2026 | 0.2791 |
| September 28, 2026 | 0.2854 |
| September 25, 2026 | 0.2854 |
| September 24, 2026 | 0.2846 |
| September 23, 2026 | 0.2846 |
| September 22, 2026 | 0.285 |
| September 21, 2026 | 0.2752 |
| September 18, 2026 | 0.2649 |
| September 17, 2026 | 0.2736 |
| September 16, 2026 | 0.2681 |
| September 15, 2026 | 0.285 |
| September 14, 2026 | 0.3003 |
| September 11, 2026 | 0.3019 |
| September 10, 2026 | 0.3168 |
| September 09, 2026 | 0.364 |
| September 08, 2026 | 0.3007 |
| September 04, 2026 | 0.305 |
| Date | Value |
|---|---|
| September 03, 2026 | 0.3082 |
| September 02, 2026 | 0.3238 |
| September 01, 2026 | 0.3086 |
| August 31, 2026 | 0.3239 |
| August 28, 2026 | 0.3274 |
| August 27, 2026 | 0.3385 |
| August 26, 2026 | 0.3404 |
| August 25, 2026 | 0.3385 |
| August 24, 2026 | 0.3184 |
| August 21, 2026 | 0.3384 |
| August 20, 2026 | 0.3585 |
| August 19, 2026 | 0.375 |
| August 18, 2026 | 0.3523 |
| August 17, 2026 | 0.3229 |
| August 14, 2026 | 0.329 |
| August 13, 2026 | 0.334 |
| August 12, 2026 | 0.3522 |
| August 11, 2026 | 0.3502 |
| August 10, 2026 | 0.373 |
| August 07, 2026 | 0.3785 |
| August 06, 2026 | 0.3767 |
| August 05, 2026 | 0.3648 |
| August 04, 2026 | 0.3619 |
| August 03, 2026 | 0.3679 |
| July 31, 2026 | 0.3906 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.703 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.729 |
| Can-Fite BioPharma Ltd. | 1.380 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| Price | 3.54 |
| Earnings Yield | -390.0% |
| Market Cap | 3.545M |